TRIUMPH-5 is registered as NCT06662383. Its direct comparison tests both treatments in adults with obesity using a shared trial protocol.
A shared protocol for two treatments
The registry lists the planned outcome and study design. Registration and an estimated completion date document the study plan. A results posting or publication is needed to interpret the findings.
How to interpret the evidence
When results become available, review the effect estimate, uncertainty and adverse events. Identify the trial’s population before applying it to broader questions.
Give the strongest weight to studies that randomized both treatments within a shared protocol for the clinical question you are asking.